{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.1/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Probenecid",
            "Path": "../../Probenecid-Model.json",
            "BuildingBlocks": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "ComparisonTimeProfile": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Unit": "µg/l",
                    "Dimension": "Concentration (mass)",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "µg/l",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "PKRatioPlots": [
                {
                    "Unit": "year(s)",
                    "Dimension": "Age",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject A_1860mg_i.v._s.d._1",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject B_1860mg_i.v._s.d._3",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject C_1860mg_i.v._s.d._5",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject D_1860mg_i.v._s.d._7",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject C_464.2mg_i.v._s.d._6",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject D_464.2mg_i.v._s.d._8",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject E_1860mg_i.v._s.d._9",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject E_464.2mg_i.v._s.d._10",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Emanuelsson 1987_500mg_i.v._s.d._14",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Landersdorfer 2009_500mg_p.o._b.i.d._21",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Landersdorfer 2010_3000mg_p.o._m.d._50",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Smith 1980_1000mg_p.o._b.i.d._6002",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Wiebe 2020_1000mg_p.o._b.i.d._6005",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject A_2000mg_p.o._s.d._2",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Dayton 1963 - Subject B_2000mg_p.o._s.d._4",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Emanuelsson 1987_1000mg_p.o._s.d._12",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Emanuelsson 1987_2000mg_p.o._s.d._13",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Emanuelsson 1987_500mg_p.o._s.d._11",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Selen 1982_1000mg_p.o._s.d._29",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Selen 1982_2000mg_p.o._s.d._30",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Selen 1982_500mg_p.o._s.d._28",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Shen 2019_1000mg_p.o._s.d._5003",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Vree 1992_1000mg_p.o._s.d._36+37",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Vree 1992_1500mg_p.o._s.d._38+39",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Vree 1992_250mg_p.o._s.d._32+33",
                "SectionId": 331
            },
            {
                "Project": "Probenecid",
                "Simulation": "Vree 1992_500mg_p.o._s.d._34+35",
                "SectionId": 332
            },
            {
                "Project": "Probenecid",
                "Simulation": "Vree 1993_1000mg_p.o._s.d._44+45",
                "SectionId": 332
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plot for concentration in plasma.",
                "SectionId": 32,
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "Probenecid iv (model building)",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject A_1860mg_i.v._s.d._1",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 1860 mg IV Subject A - Probenecid - IV - 1860 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject B_1860mg_i.v._s.d._3",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 1860 mg IV Subject B - Probenecid - IV - 1860 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject C_1860mg_i.v._s.d._5",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 1860 mg IV Subject C - Probenecid - IV - 1860 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject D_1860mg_i.v._s.d._7",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 1860 mg IV Subject D - Probenecid - IV - 1860 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject C_464.2mg_i.v._s.d._6",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 464.2 mg IV Subject C - Probenecid - IV - 464.2 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject D_464.2mg_i.v._s.d._8",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 464.2 mg IV Subject D - Probenecid - IV - 464.2 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject E_1860mg_i.v._s.d._9",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 1860 mg IV Subject E - Probenecid - IV - 1860 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject E_464.2mg_i.v._s.d._10",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 464.2 mg IV Subject E - Probenecid - IV - 464.2 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Emanuelsson 1987_500mg_i.v._s.d._14",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Emanuelsson 1987 - 500 mg iv - Probenecid - IV - 500 mg - Plasma - agg. (n=6)",
                                "Color": "#000000"
                            }
                        ]
                    },
                    {
                        "Caption": "Probenecid oral administration (model building)",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Probenecid",
                                "Simulation": "Landersdorfer 2009_500mg_p.o._b.i.d._21",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Landersdorfer 2009 - 500 mg BID - Probenecid - PO - 1000;1000;250;250;500;500;500;500; mg - Plasma - agg. (n=17)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Wiebe 2020_1000mg_p.o._b.i.d._6005",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Wiebe 2020 - 1000 mg BID Therapeutic dose - Probenecid - PO - 1000;1000 mg - Plasma - agg. (n=16)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Emanuelsson 1987_2000mg_p.o._s.d._13",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Emanuelsson 1987 - 2000 mg po - Probenecid - PO - 2000 mg - Plasma - agg. (n=6)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Selen 1982_1000mg_p.o._s.d._29",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Selen 1982 - 1000 mg po - Probenecid - PO - 1000 mg - Plasma - agg. (n=5)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Selen 1982_2000mg_p.o._s.d._30",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Selen 1982 - 2000 mg po - Probenecid - PO - 2000 mg - Plasma - agg. (n=5)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Selen 1982_500mg_p.o._s.d._28",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Selen 1982 - 500 mg po - Probenecid - PO - 500 mg - Plasma - agg. (n=5)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Vree 1992_1500mg_p.o._s.d._38+39",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vree 1992 - 1500 mg po - Probenecid - PO - 1500 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Vree 1992_250mg_p.o._s.d._32+33",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vree 1992 - 250 mg po - Probenecid - PO - 250 mg - Plasma - indiv.",
                                "Color": "#000000"
                            }
                        ]
                    },
                    {
                        "Caption": "Probenecid oral administration (model verification)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Probenecid",
                                "Simulation": "Landersdorfer 2010_3000mg_p.o._m.d._50",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Landersdorfer 2010 - 500-1000-500x3 mg - Probenecid - PO - 500;1000;500;500;500 mg - Plasma - agg. (n=12)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Smith 1980_1000mg_p.o._b.i.d._6002",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Smith 1980a - 1000 mg BID - Probenecid - PO - 1000;1000 mg - Plasma - agg. (n=4)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject A_2000mg_p.o._s.d._2",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 2000 mg PO Subject A - Probenecid - PO - 2000 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Dayton 1963 - Subject B_2000mg_p.o._s.d._4",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dayton 1963 - 2000 mg PO Subject B - Probenecid - PO - 2000 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Emanuelsson 1987_1000mg_p.o._s.d._12",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Emanuelsson 1987 - 1000 mg po - Probenecid - PO - 1000 mg - Plasma - agg. (n=6)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Emanuelsson 1987_500mg_p.o._s.d._11",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Emanuelsson 1987 - 500 mg po - Probenecid - PO - 500 mg - Plasma - agg. (n=6)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Vree 1992_1000mg_p.o._s.d._36+37",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vree 1992 - 1000 mg po - Probenecid - PO - 1000 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Vree 1992_500mg_p.o._s.d._34+35",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vree 1992 - 500 mg po - Probenecid - PO - 500 mg - Plasma - indiv.",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Probenecid",
                                "Simulation": "Vree 1993_1000mg_p.o._s.d._44+45",
                                "Output": "Organism|PeripheralVenousBlood|Probenecid|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vree 1992 - 1000 mg po - Probenecid - PO - 1000 mg - Plasma - indiv.",
                                "Color": "#000000"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Probenecid",
            "Name": "Probenecid",
            "Type": "Compound",
            "SectionId": 31
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Content": "Content/Section2.1_Modeling_Strategy.md",
                    "Title": "Modeling strategy"
                },
                {
                    "Id": 22,
                    "Content": "Content/Section2.2_Data.md",
                    "Title": "Data used"
                },
                {
                    "Id": 23,
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md",
                    "Title": "Model parameters and assumptions"
                }
            ]
        },
        {
            "Id": 3,
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Title": "Results and Discussion",
            "Sections": [
                {
                    "Id": 31,
                    "Content": "Content/Input_table.md",
                    "Title": "Probenecid final input parameters"
                },
                {
                    "Id": 32,
                    "Content": "Content/GOF_diagnostics.md",
                    "Title": "Probenecid Diagnostics Plots"
                },
                {
                    "Id": 33,
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Id": 332,
                            "Title": "Model Verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 4,
            "Content": "Content/Section4_Conclusion.md",
            "Title": "Conclusion"
        },
        {
            "Id": 5,
            "Content": "Content/References.md",
            "Title": "References"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}